Walleye Capital
NUVB icon

Walleye Capital’s Nuvation Bio NUVB Stock Holding History

Walleye Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+44,384
New +$217K ﹤0.01% 3321
2024
Q4 		– Sell
-195,131
Closed -$447K – 5323
2024
Q3 		$447K Buy
195,131
+96,184
+97% +$293K ﹤0.01% 3399
2024
Q2 		$289K Buy
+98,947
New +$302K ﹤0.01% 4011

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Walleye Capital's NUVB Position: Q2 2026 in Review

Walleye Capital opened a new position in Nuvation Bio (NUVB) in Q2 2026: 44,384 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #3321 among its holdings. This is a return to the name: Walleye Capital previously reported a position in NUVB as recently as Q3 2024.

Walleye Capital first reported a position in NUVB in Q2 2024 and has held it in 3 quarters since. The position peaked at $447K in Q3 2024. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Walleye Capital held 44,384 shares of Nuvation Bio worth $252K as of Q2 2026.
  • Nuvation Bio was a new Walleye Capital position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3321 holding.
  • Walleye Capital first reported a position in Nuvation Bio in Q2 2024 and has held it in 3 quarters since.
  • Walleye Capital's Nuvation Bio position peaked at $447K in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.